Biochemical inhibition of RIOK1 with toyocamycin led to strong antiproliferative effects in androgen receptor–negative and –positive PCa cell lines with EC50 values of 3.5 to 8.8 nmol/L. Here, AR is linked to posterior cortical atrophy.